What is JRSH's health score?

Jerash Holdings (US), Inc. (JRSH) has a TradeApes health score of 56 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is JRSH's estimated fair value?

Based on our 5-year discounted cash flow model, Jerash Holdings (US), Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is JRSH undervalued or overvalued?

Our model currently rates JRSH as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for JRSH... Refresh in a moment for the full analysis.

Jerash Holdings (US), Inc. (JRSH)

Consumer Cyclical Inconclusive inconclusive mixed

$3.4

Updated: 2026-05-30

TradeApes Score

Financial Strength

70 Healthy

Operating Trend

48 Mixed

Relative Value

60 Healthy

Capital Allocation

35 Weak

Risk

65 Healthy

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.